tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

LNTH Stock Latest News

Lantheus presents results from primary analysis of Phase 3 pivotal SPLASH trial
The FlyLantheus presents results from primary analysis of Phase 3 pivotal SPLASH trial
4d ago
LNTH
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
PremiumPress Releases
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
4d ago
LNTH
Lantheus Bolsters Board with Expert Finance Executive
PremiumCompany Announcements
Lantheus Bolsters Board with Expert Finance Executive
14d ago
8K
LNTH
Lantheus appoints Eastland as new board member
PremiumThe Fly
Lantheus appoints Eastland as new board member
14d ago
DVAX
LNTH
Lantheus Appoints Julie Eastland as New Board Member
PremiumPress Releases
Lantheus Appoints Julie Eastland as New Board Member
14d ago
LNTH
Lantheus initiated with a Buy at Redburn Atlantic
PremiumThe FlyLantheus initiated with a Buy at Redburn Atlantic
16d ago
LNTH
Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
Premium
Press Releases
Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
22d ago
LNTH
Lantheus price target lowered to $125 from $130 at JMP Securities
Premium
The Fly
Lantheus price target lowered to $125 from $130 at JMP Securities
2M ago
LNTH
Lantheus lowers 2024 adjusted EPS view $6.60-$6.70 from $7.00-$7.20
PremiumThe Fly
Lantheus lowers 2024 adjusted EPS view $6.60-$6.70 from $7.00-$7.20
2M ago
LNTH
Lantheus reports Q2 adjusted EPS $1.80, consensus $1.83
PremiumThe Fly
Lantheus reports Q2 adjusted EPS $1.80, consensus $1.83
2M ago
LNTH
Is LNTH a Buy, Before Earnings?
PremiumPre-Earnings
Is LNTH a Buy, Before Earnings?
2M ago
LNTH
Lantheus price target raised to $146 from $105 at B. Riley
PremiumThe Fly
Lantheus price target raised to $146 from $105 at B. Riley
2M ago
LNTH
Lantheus price target raised to $137 from $128 at JonesResearch
PremiumThe FlyLantheus price target raised to $137 from $128 at JonesResearch
2M ago
LNTH
Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time
Premium
Press Releases
Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time
2M ago
LNTH
Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s Disease
Premium
Press Releases
Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s Disease
2M ago
LNTH
Lantheus announces acquisition of Meilleur Technologies, NAV-4694
PremiumThe Fly
Lantheus announces acquisition of Meilleur Technologies, NAV-4694
2M ago
LNTH
Lantheus price target raised to $165 from $100 at Mizuho
PremiumThe Fly
Lantheus price target raised to $165 from $100 at Mizuho
2M ago
LNTH
Top Stock Gainers Today – QS, JOBY, and More
PremiumMarket News
Top Stock Gainers Today – QS, JOBY, and More
2M ago
QS
UP
Lantheus price target raised to $141 from $96 at Truist
PremiumThe Fly
Lantheus price target raised to $141 from $96 at Truist
2M ago
LNTH
Lantheus price target raised to $127 from $106 at Leerink
PremiumThe FlyLantheus price target raised to $127 from $106 at Leerink
2M ago
LNTH
Lantheus price target raised to $130 from $100 at JMP Securities
Premium
The Fly
Lantheus price target raised to $130 from $100 at JMP Securities
2M ago
LNTH
Lantheus price target raised to $130 from $100 at JMP Securities
Premium
The Fly
Lantheus price target raised to $130 from $100 at JMP Securities
2M ago
LNTH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >